Found 45 clinical trials
Global Healthy Living Foundation, The COvid19 Vaccine Response in Rheumatology patients (COVER) (Pro00054507)
Observational BOOSTER study to evaluate SARS-CoV-2 vaccines in a large population of patients with autoimmune conditions
- 0 views
- 30 Dec, 2022
- 1 location
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
- 290 views
- 25 Mar, 2021
- 1 location
EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) WITH ACTIVE SYSTEMIC FEATURES IN CHILDREN AND ADOLESCENT SUBJECTS
A randomized withdrawal study in which responders to open-label treatment with tofacitinib will be randomized in a 1:1 ratio to tofacitinib or placebo in a double-blind phase. In the double
- 134 views
- 28 Oct, 2022
- 39 locations
RA-PRO PRAGMATIC TRIAL (RA-PROPR)
medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (tsDMARD; choose among existing medications, currently, tofacitinib, baricitinib, upadacitinib) in
- 0 views
- 28 Jun, 2022
- 1 location
Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management
The TRIUMPH study was designed to build on the existing literature by studying the efficacy of tofacitinib in hospitalized patients with acute severe ulcerative colitis. This trial will provide
- 0 views
- 24 Jun, 2021
- 1 location
The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis
treatment of RA, tofacitinib can relieve RA symptoms and promote joint healing It can recover the injury and correct the abnormal immune function. At present, studies have proved that the traditional anti
- 8 views
- 22 Jun, 2021
- 1 location
The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis
This is a randomized, double-blind, double-dummy, tofacitinib-parallel-group, phase 2A study to assess the safety and efficacy of TLL-018 in active rheumatoid arthritis subject who had an
- 9 views
- 25 Apr, 2022
- 1 location
Combination of Baricitinib and Adalimumab in Rheumatoid Arthritis (CRI-RA)
, combination of tofacitinib (which belongs to the same Jaki family as baricitinib) with various biologics has been reported in a sample of RA patients. No serious adverse effects were reported over a mean of
- 0 views
- 15 Mar, 2022
- 6 locations
Real-world Experience With Inhibitors of Janus Kinase for the Treatment of Idiopathic Inflammatory Myopathies -- a Prospective Observational Study
This study aims to explore the clinical characteristics and mechanism of inhibitors of janus kinase in the treatment of idiopathic inflammatory myopathies
- 0 views
- 21 Oct, 2022
- 1 location
A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)
Evaluate long-term safety and tolerability of tofacitinib in patients with JIA, who have previously participated in tofacitinib JIA studies.
- 319 views
- 28 Oct, 2022
- 37 locations